Your browser doesn't support javascript.
loading
'Twenty years of network meta-analysis: Continuing controversies and recent developments': A health technology assessment perspective.
Jackson, Dan; Zhang, Landan; Hettle, Robert; Cooper, Miranda.
Affiliation
  • Jackson D; Statistical Innovation Group, AstraZeneca, Cambridge, UK.
  • Zhang L; Statistical Innovation Group, AstraZeneca, Cambridge, UK.
  • Hettle R; Health Technology Assessment and Modelling Science, AstraZeneca, Cambridge, UK.
  • Cooper M; Oncology Biometrics, AstraZeneca, Cambridge, UK.
Res Synth Methods ; 2024 Jul 30.
Article de En | MEDLINE | ID: mdl-39076063
ABSTRACT
We respond to some of the methodological issues raised in a recent review of network meta-analysis (NMA). We also provide a health technology developer's perspective and consider the future application of NMA to health technology assessment.
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Res Synth Methods Année: 2024 Type de document: Article Pays d'affiliation: Royaume-Uni
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Res Synth Methods Année: 2024 Type de document: Article Pays d'affiliation: Royaume-Uni